(19)
(11) EP 1 003 751 A1

(12)

(43) Date of publication:
31.05.2000 Bulletin 2000/22

(21) Application number: 98939182.6

(22) Date of filing: 04.08.1998
(51) International Patent Classification (IPC)7C07D 495/04, A61K 31/44, A61K 31/55, C07D 491/048, C07D 498/04, C07D 513/04
// (C07D495/04, 333:00), C07D221:00,(C07D495/04, 333:00), C07D223:00,(C07D495/04, 333:00), C07D225:00
(86) International application number:
PCT/US9816/147
(87) International publication number:
WO 9906/410 (11.02.1999 Gazette 1999/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.08.1997 US 54753 P
03.08.1998 US 128512

(71) Applicant: AMGEN INC.
Thousand Oaks, CA 91320-1789 (US)

(72) Inventors:
  • THOMSON, David, S.
    Boulder, CO 80301 (US)
  • KOCH, Kevin
    Boulder, CO 80301 (US)
  • HWANG, Chan, Kou
    Boulder, CO 80304 (US)
  • RUSSO-RODRIGUEZ, Sandra, E.
    Superior, CO 80027 (US)
  • HUMMEL, Conrad
    Louisville, CO 80027 (US)

(74) Representative: Richardson, Kate et al
Forrester & Boehmert,Franz-Joseph Strasse 38
80801 München
80801 München (DE)

   


(54) HYDROXAMIC ACID SUBSTITUTED FUSED HETEROCYCLIC METALLOPROTEINASE INHIBITORS